No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Aminobutyrates / therapeutic use
-
Angiotensin Receptor Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Biphenyl Compounds
-
Cardiovascular Agents / therapeutic use
-
Drug Combinations
-
Female
-
Heart Failure / blood
-
Heart Failure / drug therapy*
-
Humans
-
Interleukin-1 Receptor-Like 1 Protein / blood*
-
Ivabradine / therapeutic use
-
Male
-
Mineralocorticoid Receptor Antagonists / therapeutic use
-
Patient Care Planning
-
Patient Readmission*
-
Randomized Controlled Trials as Topic
-
Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
-
Tetrazoles / therapeutic use
-
Valsartan
Substances
-
Adrenergic beta-Antagonists
-
Aminobutyrates
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Biphenyl Compounds
-
Cardiovascular Agents
-
Drug Combinations
-
IL1RL1 protein, human
-
Interleukin-1 Receptor-Like 1 Protein
-
Mineralocorticoid Receptor Antagonists
-
Sodium Potassium Chloride Symporter Inhibitors
-
Tetrazoles
-
Ivabradine
-
Valsartan
-
sacubitril and valsartan sodium hydrate drug combination